Caisse DE Depot ET Placement DU Quebec lifted its stake in shares of CME Group Inc (NASDAQ:CME) by 9.9% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 7,791 shares of the financial services provider’s stock after acquiring an additional 700 shares during the quarter. Caisse DE Depot ET Placement DU Quebec’s holdings in CME Group were worth $1,062,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CME. Fiduciary Trust Co. bought a new stake in shares of CME Group during the 2nd quarter worth about $105,000. Quadrant Capital Group LLC boosted its stake in CME Group by 13.6% during the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock valued at $111,000 after purchasing an additional 113 shares during the period. San Francisco Sentry Investment Group CA bought a new stake in CME Group during the 2nd quarter valued at approximately $129,000. People s United Financial Inc. boosted its stake in CME Group by 11.5% during the 2nd quarter. People s United Financial Inc. now owns 1,063 shares of the financial services provider’s stock valued at $133,000 after purchasing an additional 110 shares during the period. Finally, Parallel Advisors LLC boosted its stake in CME Group by 12.2% during the 2nd quarter. Parallel Advisors LLC now owns 1,216 shares of the financial services provider’s stock valued at $149,000 after purchasing an additional 132 shares during the period. Institutional investors own 83.17% of the company’s stock.

In other news, CFO John W. Pietrowicz sold 2,500 shares of the stock in a transaction that occurred on Wednesday, October 11th. The stock was sold at an average price of $136.83, for a total value of $342,075.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Julie Winkler sold 2,457 shares of the stock in a transaction that occurred on Thursday, December 7th. The stock was sold at an average price of $150.41, for a total value of $369,557.37. Following the completion of the transaction, the insider now directly owns 16,318 shares of the company’s stock, valued at $2,454,390.38. The disclosure for this sale can be found here. In the last ninety days, insiders sold 36,628 shares of company stock valued at $5,288,800. Insiders own 0.57% of the company’s stock.

CME Group Inc (CME) opened at $151.61 on Thursday. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11. The company has a market capitalization of $51,590.00, a P/E ratio of 31.95, a price-to-earnings-growth ratio of 3.14 and a beta of 0.73. CME Group Inc has a twelve month low of $113.27 and a twelve month high of $155.29.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, beating the consensus estimate of $1.16 by $0.03. The firm had revenue of $890.80 million during the quarter, compared to analysts’ expectations of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. The company’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.05 EPS. equities research analysts expect that CME Group Inc will post 4.78 earnings per share for the current year.

The company also recently declared a None dividend, which will be paid on Monday, January 15th. Shareholders of record on Thursday, December 28th will be issued a $3.50 dividend. The ex-dividend date is Wednesday, December 27th. CME Group’s dividend payout ratio (DPR) is 59.86%.

CME has been the subject of several recent analyst reports. Wells Fargo & Company increased their target price on CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a research note on Wednesday, October 4th. Royal Bank of Canada increased their target price on CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a research note on Monday, October 16th. BidaskClub upgraded CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, December 6th. Barclays initiated coverage on CME Group in a research note on Friday, September 8th. They set an “overweight” rating and a $139.00 target price for the company. Finally, Keefe, Bruyette & Woods restated a “hold” rating and set a $133.00 target price on shares of CME Group in a research note on Thursday, September 21st. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company. CME Group has a consensus rating of “Buy” and a consensus price target of $141.75.

COPYRIGHT VIOLATION NOTICE: “CME Group Inc (CME) Stake Increased by Caisse DE Depot ET Placement DU Quebec” was originally published by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of US & international trademark and copyright laws. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/12/14/cme-group-inc-cme-stake-increased-by-caisse-de-depot-et-placement-du-quebec.html.

CME Group Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.